康弘药业 is a large pharmaceutical group engaged in the research and development, production, sales, and after-sales service of traditional Chinese medicine, chemical drugs, and biological products.

康弘药业

Chengdu Kanghong Pharmaceutical Group Co.,Ltd. | 2,265 followers on LinkedIn. 成都康弘药业集团股份有限公司（以下简称康弘药业）是一家致力于中成药、化学药及生物制品的研发、生产、销售及售后服务的医药集团，总部位于四川省成都市，现有员工4000余人，拥有中成药、化学药和生物制品生产基地，销售网络遍布全国。
        自成立以来，康弘药业获得了各级政府的关心指导及社会各界的广泛关注：2008年，在国家商务部委托中国化学制药工业协会组织的首批全国制药企业信用评价中，康弘药业成为全国仅有的七家获得“AAA级企业信用等级”的制药企业之一，同时也是四川省唯一一家授信企业，并在2012年再次被评为“AAA级企业信用等级”企业；2009年，康弘药业“”商标被国家工商总局认定为“中国驰名商标”。同年，康弘药业荣获中国医药企业管理协会与搜狐网联合颁发的中国医药30年风云会改革开放30年“创新奖”；2010年，被国家知识产权局列入“全国企事业知识产权试点单位”；2011年，被中国化学工业协会评为“中国化学制药行业创新型企业品牌十强”；2012年，被国家科技部，国务院国资委、中华全国总工会列入国家第五批“创新型试点企业”。

Vice President， Head of Biologics at Chengdu Kanghong Pharmaceutical Group Co.,Ltd.

Xiao Feng

成都康弘药业集团股份有限公司 - 医学经理

Lucy Lee

成都康弘生物科技有限公司 - 无菌技术工程师

王茜

Patient education specialist HR

Nancy Chen

Chengdu Kanghong Pharmaceutical Group Co.,Ltd.

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Euro

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Content Delivery Network

Senior Clinical Development Manager

Anna Oughton

Investigational Product Study Supply Lead

Ziyu Ouyang

HR Specialist (Vanotech Ltd, a US Subsidiary of Kanghong Pharmaceutical)

Hui Wang

XiaoFeng Hao

Manufacturing Public Companies With More Than 1000 Employees

China Companies With More Than 100 Employees (Top 10K)

Asia-Pacific (APAC) Public Companies With More Than 500 Employees (Top 10K)

Asia Pharmaceutical Companies

Chengdu Kanghong Pharmaceutical Group has pharmaceutical products and knowledge that fundamentally improve the individual physical fitness of patients and social medical efficiency. It develops, manufactures, and sells traditional Chinese medicines, chemical drugs, and biologicals.

Chengdu

Sichuan

China

Asia

Chengdu Kanghong Pharmaceutical Group

Chengdu Kanghong Pharmaceutical divulges new GLP-1R agonists

Chengdu Kanghong Pharmaceutical patents new Nav1.8 blockers

A biologic injection used for treating eye conditions such as age-related macular degeneration and diabetic macular edema.

A chemical drug in tablet form used for the treatment of depression.

An oral solution used for treating schizophrenia and other mental health disorders.

A chemical drug used for treating depression and panic disorders.

A traditional Chinese medicine used for treating mild to moderate depression.

A chemical drug under development for the treatment of depression.

Nigeria

Africa

Hong Kong

Taiwan

Singapore

Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research, development, production, and sale of biological products, Chinese medicines, and chemical drugs in China. It offers ophthalmic systems, central nervous systems, digestive systems, and other system drugs. The company was founded in 1996 and is headquartered in Chengdu, China.

Chengdu Kanghong Pharmaceutical Group Co., Ltd

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 8:43 PM	b778b5b2
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 8:43 PM	d126d62a
crunchbase trigger	general	Nov 17, 2024 8:43 PM	e4f9e26b
crunchbase profile	general	Nov 17, 2024 9:04 PM	ec488f67
li profile	general	Nov 17, 2024 8:43 PM	6ef85859
translate crunchbase fundingrounds	general	Nov 17, 2024 9:30 PM	b874ed21
peers	general	Nov 17, 2024 8:43 PM	49b24587
news basic	general	Nov 17, 2024 8:43 PM	84b36537
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

0027

COM:CNKH

康弘药业

Last Close

20.05

22/11 07:04

Market Cap

20.19B

Beta: -

Volume Today

12.12M

Avg: -